290 related articles for article (PubMed ID: 26877609)
1. Glucose metabolism in gastric cancer: The cutting-edge.
Yuan LW; Yamashita H; Seto Y
World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
[TBL] [Abstract][Full Text] [Related]
2. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
[TBL] [Abstract][Full Text] [Related]
3. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
Chen DH; Yu JW; Jiang BJ
World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic studies of human gastric cancer: review.
Jayavelu ND; Bar NS
World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer: Metabolic and metabolomics perspectives (Review).
Xiao S; Zhou L
Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.
Yashiro M; Matsuoka T
World J Gastroenterol; 2016 Feb; 22(8):2415-23. PubMed ID: 26937130
[TBL] [Abstract][Full Text] [Related]
7. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and metabolic prediction of response to therapy in gastric cancer.
Aichler M; Luber B; Lordick F; Walch A
World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
[TBL] [Abstract][Full Text] [Related]
9. Targeting hypoxic response for cancer therapy.
Paolicchi E; Gemignani F; Krstic-Demonacos M; Dedhar S; Mutti L; Landi S
Oncotarget; 2016 Mar; 7(12):13464-78. PubMed ID: 26859576
[TBL] [Abstract][Full Text] [Related]
10. Potential role of metabolomics in diagnosis and surveillance of gastric cancer.
Chan AW; Gill RS; Schiller D; Sawyer MB
World J Gastroenterol; 2014 Sep; 20(36):12874-82. PubMed ID: 25278684
[TBL] [Abstract][Full Text] [Related]
11. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
Xuan Y; Hur H; Ham IH; Yun J; Lee JY; Shim W; Kim YB; Lee G; Han SU; Cho YK
Exp Cell Res; 2014 Feb; 321(2):219-30. PubMed ID: 24342832
[TBL] [Abstract][Full Text] [Related]
12. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
13. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
14. Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies.
Majeed W; Iftikhar A; Khaliq T; Aslam B; Muzaffar H; Atta K; Mahmood A; Waris S
Asian Pac J Cancer Prev; 2016; 17(7):3053-60. PubMed ID: 27509928
[TBL] [Abstract][Full Text] [Related]
15. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
16. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.
Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C
Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells.
Qin W; Li C; Zheng W; Guo Q; Zhang Y; Kang M; Zhang B; Yang B; Li B; Yang H; Wu Y
Oncotarget; 2015 Nov; 6(37):39839-54. PubMed ID: 26497999
[TBL] [Abstract][Full Text] [Related]
18. A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer.
Wang X; Yan SK; Dai WX; Liu XR; Zhang WD; Wang JJ
Int J Cancer; 2010 Dec; 127(12):2841-50. PubMed ID: 21351263
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
